Scherer, D., Xynogalos, P., Scholz, E. P., Thomas, D., Katus, H., & Zitron, E. (2017). Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP2 interference. Naunyn-Schmiedeberg's archives of pharmacology, 390(7), . https://doi.org/10.1007/s00210-017-1372-5
Chicago-Zitierstil (17. Ausg.)Scherer, Daniel, Panagiotis Xynogalos, Eberhard P. Scholz, Dierk Thomas, Hugo Katus, und Edgar Zitron. "Inhibition of Inwardly Rectifying Kir2.x Channels by the Novel Anti-cancer Agent Gambogic Acid Depends on Both Pore Block and PIP2 Interference." Naunyn-Schmiedeberg's Archives of Pharmacology 390, no. 7 (2017). https://doi.org/10.1007/s00210-017-1372-5.
MLA-Zitierstil (9. Ausg.)Scherer, Daniel, et al. "Inhibition of Inwardly Rectifying Kir2.x Channels by the Novel Anti-cancer Agent Gambogic Acid Depends on Both Pore Block and PIP2 Interference." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 390, no. 7, 2017, https://doi.org/10.1007/s00210-017-1372-5.